# SILODOSIN
> **ANDA204816** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-12-08
## Drug
- **FDA Application Number:** ANDA204816
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILODOSIN
- **Generic name:** Silodosin
- **Active ingredients:** SILODOSIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2022-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204816)
---
*MORVS · CC0 1.0*